The annual price of monoclonal antibody therapies used in oncology and hematology is about $100,000 higher than those used in other disease states.
Shivani Sampathkumar, BS
Advertisement
Articles by Shivani Sampathkumar, BS
Advertisement
Latest Updated Articles
- Pricing of Monoclonal Antibody Therapies: Higher If Used for Cancer?
February 14th 2018
Advertisement
Advertisement
Trending on AJMC
1
Vutrisiran Effects Consistent With, Without Tafamidis in ATTR-CM
2
FDA Approves Camizestrant for ER+, HER2– mBC With ESR1 Mutations
3
Multiagonists Outpace Older GLP-1 Drugs for Weight Loss
4
Cardiac Risks of COVID-19 Vaccine vs Infection: Eman Toraih, MD, PhD
5